Biosimilars: What's in Store for Major Biopharmaceutical Products?

   Single User - $0

Published Jan 11, 2018 | 3 Pages | Pub ID: KLI15571151

This brief White paper discusses "biosimilars," close copies of biopharmaceutical drug processes that compete with major brands.  The concept represents a threat and an opportunity for pharmaceutical companies.  For more information, please see Kalorama Informaiton's full market research study: Biosimilars: Global Market, Trends and Competitor Analysis
  • Introduction
  • Size of the Market
  • Major Brands
  • Focus on India
  • About our Study, Biosimilars: Global Market, Trends and Competitor Analysis

In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.